Literature DB >> 29254757

First Trimester Plasma Glucose Values in Women without Diabetes are Associated with Risk for Congenital Heart Disease in Offspring.

Emmi I T Helle1, Preston Biegley2, Joshua W Knowles3, Joseph B Leader2, Sarah Pendergrass2, Wei Yang4, Gerald R Reaven3, Gary M Shaw4, Marylyn Ritchie2, James R Priest5.   

Abstract

In a retrospective study of 19 171 mother-child dyads, elevated random plasma glucose values during early pregnancy were directly correlated with increased risk for congenital heart disease in offspring. Plasma glucose levels proximal to the period of cardiac development may represent a modifiable risk factor for congenital heart disease in expectant mothers without diabetes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congenital heart disease; congenital malformation; diabetes; oral glucose tolerance test; plasma glucose

Mesh：

Substances：

Year:  2017        PMID： 29254757      PMCID： PMC5869072          DOI： 10.1016/j.jpeds.2017.10.046

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  14 in total

1.  Prediction of gestational diabetes mellitus at 24 to 28 weeks of gestation by using first-trimester insulin sensitivity indices in Asian Indian subjects.

Authors:  Emmy Grewal; Sandeep Kansara; Garima Kachhawa; A C Ammini; Alka Kriplani; Nutan Aggarwal; Nandita Gupta; Rajesh Khadgawat
Journal:  Metabolism       Date:  2011-12-05       Impact factor: 8.694

2.  Prevalence of Diabetes in the United States: A Glimmer of Hope?

Authors:  William H Herman; Amy E Rothberg
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

3.  Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus.

Authors:  Satoko Endo; Kazuhisa Maeda; Masanori Suto; Takashi Kaji; Mikio Morine; Toshiko Kinoshita; Toshiyuki Yasui; Minoru Irahara
Journal:  Gynecol Endocrinol       Date:  2006-06       Impact factor: 2.260

4.  High glucose concentration inhibits migration of rat cranial neural crest cells in vitro.

Authors:  N Suzuki; K Svensson; U J Eriksson
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

5.  Congenital heart disease in infants of diabetic mothers.

Authors:  T W Rowland; J P Hubbell; A S Nadas
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

Review 6.  Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis.

Authors:  Lukas A Lisowski; Paul M Verheijen; Joshua A Copel; Charles S Kleinman; Sander Wassink; Gerard H A Visser; Erik-Jan Meijboom
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

7.  Characterization of conotruncal malformations following ablation of "cardiac" neural crest.

Authors:  M L Kirby; K L Turnage; B M Hays
Journal:  Anat Rec       Date:  1985-09

8.  Normal fasting plasma glucose levels during pregnancy: a hospital-based study.

Authors:  Shlomit Riskin-Mashiah; Amit Damti; Grace Younes; Ron Auslander
Journal:  J Perinat Med       Date:  2011-01-18       Impact factor: 1.901

9.  Human cardiac development in the first trimester: a high-resolution magnetic resonance imaging and episcopic fluorescence image capture atlas.

Authors:  Preeta Dhanantwari; Elaine Lee; Anita Krishnan; Rajeev Samtani; Shigehito Yamada; Stasia Anderson; Elizabeth Lockett; Mary Donofrio; Kohei Shiota; Linda Leatherbury; Cecilia W Lo
Journal:  Circulation       Date:  2009-07-28       Impact factor: 29.690

10.  Maternal Midpregnancy Glucose Levels and Risk of Congenital Heart Disease in Offspring.

Authors:  James R Priest; Wei Yang; Gerald Reaven; Joshua W Knowles; Gary M Shaw
Journal:  JAMA Pediatr       Date:  2015-12       Impact factor: 16.193
View more
  9 in total

Review 1.  Impact of maternal hyperglycemia on cardiac development: Insights from animal models.

Authors:  Talita Z Choudhury; Uddalak Majumdar; Madhumita Basu; Vidu Garg
Journal:  Genesis       Date:  2021-09-09       Impact factor: 2.487

Review 2.  Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes.

Authors:  Mary R Loeken
Journal:  Curr Diab Rep       Date:  2020-09-12       Impact factor: 4.810

Review 3.  Maternal hyperglycemia and fetal cardiac development: Clinical impact and underlying mechanisms.

Authors:  Madhumita Basu; Vidu Garg
Journal:  Birth Defects Res       Date:  2018-12-01       Impact factor: 2.344

Review 4.  Genetic evaluation of patients with congenital heart disease.

Authors:  Gabrielle C Geddes; Michael G Earing
Journal:  Curr Opin Pediatr       Date:  2018-12       Impact factor: 2.856

Review 5.  Epigenetics and Mechanobiology in Heart Development and Congenital Heart Disease.

Authors:  Dillon K Jarrell; Mallory L Lennon; Jeffrey G Jacot
Journal:  Diseases       Date:  2019-09-01

6.  Activating transcription factor 3 coordinates differentiation of cardiac and hematopoietic progenitors by regulating glucose metabolism.

Authors:  Hui-Min Yin; Li-Feng Yan; Qian Liu; Zheng Peng; Chi-Yuan Zhang; Yu Xia; Dan Su; Ai-Hua Gu; Yong Zhou
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

7.  Using Innovative Machine Learning Methods to Screen and Identify Predictors of Congenital Heart Diseases.

Authors:  Yanji Qu; Xinlei Deng; Shao Lin; Fengzhen Han; Howard H Chang; Yanqiu Ou; Zhiqiang Nie; Jinzhuang Mai; Ximeng Wang; Xiangmin Gao; Yong Wu; Jimei Chen; Jian Zhuang; Ian Ryan; Xiaoqing Liu
Journal:  Front Cardiovasc Med       Date:  2022-01-07

8.  Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study.

Authors:  Helen Dolk; Nichola McCullough; Sinead Callaghan; Frank Casey; Brian Craig; Joanne Given; Maria Loane; Briege M Lagan; Brendan Bunting; Breidge Boyle; Tabib Dabir
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

Review 9.  Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart Disease in the Offspring.

Authors:  Emmi Helle; James R Priest
Journal:  J Am Heart Assoc       Date:  2020-04-20       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.